Psoriasis - Biologics Impact Treatment Regimes Across the Globe

Questions: Discounts, Updates etc.

Price: $15,200.00

Publication Date: 2005-02-11

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Psoriasis is a non-life threatening but highly debilitating disease that currently has no cure. Traditional treatments often either lack efficacy or are effective but have very poor side-effect profiles, limiting them to use in severe disease only. However, the market is growing as disease awareness increases through the approval and marketing of novel biologic treatments in this indication.


Scope

  • Overview of disease including detailed epidemiology, physician estimated diagnosis rates and severity split
  • Breakdown of treatment trends in the following markets: US, Japan, France, Germany, Italy, Spain and the UK
  • Survey of PCPs and dermatologists in the major markets to capture the treatment of the ranging severities of psoriasis, from mild to severe patients
  • Review of current treatment options and clinical debate including comments from key opinion leaders


    • Report Highlights
    Psoriasis is currently under diagnosed with an average of 55% of sufferers diagnosed by a physician. However, awareness of the debilitating nature of this disease is increasing, driven by the introduction of high profile biologic brands into the market.

    Topical treatments such as calcipotriol and corticosteroids still dominate psoriasis treatment, leaving a gap for the moderate severity patient not effectively treated by this group, but not severe enough for an expensive or toxic systemic treatment.

    Current and pipeline biologic brands are differentiated from selected traditional brands by their perceived superior efficacy, side-effect profile, dosing frequency and ability to treat comorbidities.


    Reasons to Purchase

  • Differentiate your product in the crowded psoriasis market through an understanding of physician perceptions of key product brands
  • Identify unmet needs and the most important attributes to prescribing physicians for steroidal, biologic and vitamin derivative treatment classes
  • Forecast product usage across the seven major markets based on estimated treatment class patient numbers

    • Table of Contents

    Other users found this report page using the following search terms: psoriasis autoimmune psoriasis biologics treatment life quality table dermatology cost psoriasis attributes

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.